by Jennifer P | Apr 29, 2021 | Canadian Regulatory, OTC Drugs
The deadline for the first step of Health Canada’s risk evaluation for the presence of N-nitrosamine impurities in Canadian human pharmaceutical, biological and radiopharmaceutical products was March 31, 2021. This deadline applied to Market Authorization Holders...
by Jennifer P | Apr 29, 2021 | Canadian Regulatory, Cosmetics, Natural Health Products, OTC Drugs
The Government of Canada conducts risk assessments of substances under the Canadian Environmental Protection Act, 1999 (CEPA) to determine whether they present or may present a risk to human health or to the environment. A final risk assessment was recently completed...
Recent Comments